Gut bacteria shifts worsen liver cirrhosis and heart failure, study reveals

A new study by Wang et al. has revealed how gut health directly affects chronic diseases like liver cirrhosis and heart failure. Researchers found that intestinal congestion leads to harmful changes in gut bacteria, worsening these conditions. The findings suggest that treating gut imbalances could become a key part of managing such illnesses.

The study identified three major shifts in gut bacteria caused by intestinal stasis in patients with liver cirrhosis or heart failure. Proteobacteria levels rose sharply, while the ratio of Bacteroidetes to Firmicutes dropped. At the same time, dangerous Enterobacteriaceae bacteria became more prevalent.

These microbial changes disrupt short-chain fatty acid production, fuelling inflammation and systemic dysfunction. Gut dysbiosis also weakens hemodynamic stability, speeding up disease progression. Probiotics and prebiotics may help restore balance, but researchers stress the need to map out the exact biochemical pathways involved.

Experts now recommend closer collaboration between gastroenterologists, cardiologists, hepatologists, and microbiologists. By integrating gut health assessments into treatment plans, they hope to improve outcomes for patients with chronic conditions. Better fluid management and targeted probiotic therapies could also cut hospital readmissions and healthcare costs.

The study highlights the gut's central role in liver and heart diseases, pushing for a shift in how these conditions are treated. Future research will focus on pinpointing which microbial populations are most affected by congestion. This could lead to more precise therapies that address both gut and systemic health.